Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

This prospective study was conducted with the Korean Cancer Study Group to evaluate the efficacy and safety of cetuximab combined with modified FOLFOX6 (mFOLFOX6) as first-line treatment in recurrent or metastatic gastric cancer and to identify potential predictive biomarkers. Patients received cetu...

詳細記述

保存先:
書誌詳細
主要な著者: Han, S-W, Oh, D-Y, Im, S-A, Park, S R, Lee, K-W, Song, H S, Lee, N-S, Lee, K H, Choi, I S, Lee, M H, Kim, M A, Kim, W H, Bang, Y-J, Kim, T-Y
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2009
主題:
Clinical Study
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2634707/
https://ncbi.nlm.nih.gov/pubmed/19127259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604861
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料